Tatyana Der

Statistics

Publications

Citations

276

H-Index

Active since

2013

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

Harvard University

National Institutes of Health

University of California, San Francisco

Stanford University

Tatyana Der is an author at National Institute of Allergy and Infectious Diseases specializing in pharmacotherapy, primary outcome analysis, and medicine.

ORCID

Publications per year

2013–2024

Publications

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom et al. · JAMA · 2023 · 67 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +11

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Deborah Wentworth, Andrew Phillips, Kathryn Shaw‐Saliba et al. · Annals of Internal Medicine · 2022 · 63 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

Tracy Y. Wang, Abdus S. Wahed, Alison Morris et al. · Annals of Internal Medicine · 2023 · 36 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

HIF-1α in heart: Protective mechanisms

Ping Chen, Ying Li, Chris L Ardell et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 28 citations · Full text

Life Sciences, Cardiology, Physiology +15

1–5 of 8